Phase I Study of FT538 Monotherapy and in Combination with Vorinostat for the Treatment of Persistent Low-Level HIV Viremia

Project: Research project

Project Details

Description

Phase I Study of FT538 Monotherapy and in Combination with Vorinostat for the Treatment of Persistent Low-Level HIV Viremia
StatusActive
Effective start/end date7/11/227/31/28

Funding

  • FATE THERAPEUTICS, INC.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.